Funder
Tianjin Science and Technology Committee
Ministry of Science and Technology of the People's Republic of China
Publisher
Springer Science and Business Media LLC
Subject
Agricultural and Biological Sciences (miscellaneous),Environmental Science (miscellaneous),Biotechnology
Reference47 articles.
1. Arita K, South AP, Hans-Filho G, Sakuma TH, Lai-Cheong J et al (2008) Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis. Am J Hum Genet 82:73–80
2. Bammert GF, Dunham SA (2017) Interleukin-31 monoclonal antibody. European patent 3219729A1
3. Bammert GF, Gonzales AJ (2022) Antibodies to canine and feline Oncostatin M receptor beta and uses thereof. World Intellectual Property Organization 2022/086837A1
4. Bilsborough J, Leung DY, Maurer M, Howell M, Boguniewicz M et al (2006) IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol 117:418–425
5. Caffarel MM, Coleman N (2014) Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma. J Pathol 232:386–390